Fertility drugs don't raise risk of uterine cancer recurrence

12/26/2012 | PhysiciansBriefing.com

Women who took fertility drugs after fertility-sparing therapy for uterine cancer were not more likely to experience recurrence than those who didn't receive fertility drugs, according to a review in the journal Obstetrics & Gynecology. Researchers looked at data on 141 patients and found a similar rate of five-year disease-free survival among women who did and didn't take fertility treatments.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC